文献速递外周动脉疾病

合并抑郁症与外周动脉疾病退伍军人死亡和截肢的关联

The association of comorbid depression with mortality and amputation in veterans with peripheral artery disease.
PubMed 文献 · J Vasc Surg · 2018-03-24

这项观察性回顾性队列研究纳入155,647例外周动脉疾病(PAD)退伍军人(2003-2014年),抑郁症患病率为16%。校正协变量后,合并抑郁症与截肢风险升高13%(HR 1.13;95%CI 1.07-1.19)和死亡风险升高17%(HR 1.17;95%CI 1.14-1.20)相关;未接受抗抑郁药治疗的抑郁症患者截肢风险较无抑郁症者高42%(HR 1.42;95%CI 1.27-1.58)。

要点

  • 合并抑郁症的PAD退伍军人截肢风险升高13%、死亡风险升高17%。
  • 未治疗抑郁症患者截肢风险较无抑郁症者高42%(HR 1.42)。
  • 接受抗抑郁药治疗的抑郁症患者截肢风险仍较无抑郁症者高10%(HR 1.10)。

核心结论

  • 合并抑郁症的PAD患者截肢和死亡风险显著高于无抑郁症的PAD患者。
  • 未治疗的抑郁症与PAD人群截肢风险升高相关,程度高于正在接受抗抑郁药治疗的抑郁症或其他精神疾病。
  • 抗抑郁药治疗与截肢风险的关联应促使进一步研究未治疗抑郁症与血管功能障碍之间可能的机制联系。

研究设计与样本

  • 观察性回顾性队列研究,纳入美国退伍军人健康管理局全国医院2003-2014年155,647例新发PAD患者。
  • 使用退伍军人事务部企业数据仓库数据,通过PAD诊断前或后6个月内的国际疾病分类第九版诊断代码判定抑郁症。
  • 主要结局为新发大截肢和全因死亡,采用Kaplan-Meier图评估粗关联,采用Cox比例风险模型分析校正协变量后的效应。

主要发现

  • 队列中抑郁症患病率为16%,共发生9,517例截肢和63,287例死亡,中位随访5.9年。
  • 未校正时,合并抑郁症对截肢和全因死亡的风险比分别为1.32(95%CI 1.25-1.39)和1.02(95%CI 0.99-1.04)。
  • 校正协变量后,PAD诊断时合并抑郁症与无抑郁症者相比,截肢风险升高13%(HR 1.13;95%CI 1.07-1.19),死亡风险升高17%(HR 1.17;95%CI 1.14-1.20)。
  • 按抗抑郁药使用分层,未服用抗抑郁药的抑郁症患者较无抑郁症者截肢风险升高42%(HR 1.42;95%CI 1.27-1.58)。
  • 因抑郁症服用抗抑郁药的患者较无抑郁症者截肢风险仍升高10%(HR 1.10;95%CI 1.03-1.17);因其他适应症服用抗抑郁药者较无抑郁症且未服用抗抑郁药者截肢风险升高(HR 1.08;95%CI 1.03-1.14)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 因果关系的基础机制(如有)仍有待确定。
  • 抗抑郁药治疗使用与截肢风险的关联应促使进一步研究未治疗抑郁症与血管功能障碍之间可能的机制联系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Peripheral artery disease (PAD) is an increasing health concern with rising incidence globally. Previous studies have shown an association between PAD incidence and depression. The objective of the study was to determine the association of comorbid depression with PAD outcomes (amputation and all-cause mortality rates) in veterans. METHODS: An observational retrospective cohort of 155,647 patients with incident PAD (2003-2014) from nationwide U.S. Veterans Health Administration hospitals was conducted using the national Veterans Affairs Corporate Data Warehouse. Depression was measured using concurrent International Classification of Diseases, Ninth Revision diagnosis codes 6 months before or after PAD diagnosis. The main outcomes were incident major amputation and all-cause mortality. Crude associations were assessed with Kaplan-Meier plots. The effects of depression adjusted for covariates were analyzed using Cox proportional hazards models. RESULTS: Depression was present in 16% of the cohort, with the occurrence of 9517 amputations and 63,287 deaths (median follow-up, 5.9 years). Unadjusted hazard ratios (HRs) of comorbid depression for amputations and all-cause mortality were 1.32 (95% confidence interval [CI], 1.25-1.39) and 1.02 (95% CI, 0.99-1.04), respectively. After adjustment for covariates in Cox regression models, a diagnosis of comorbid depression at the time of PAD diagnosis was associated with a 13% higher amputation (HR, 1.13; 95% CI, 1.07-1.19) and 17% higher mortality (HR, 1.17; 95% CI, 1.14-1.20) risk compared with patients with no depression. On stratification by use of antidepressants, depressed patients not taking antidepressants had a 42% higher risk of amputation (HR, 1.42; 95% CI, 1.27-1.58) compared with those without depression. Patients taking antidepressants for depression still had increased risk of amputation but only 10% higher compared with those without depression (HR, 1.10; 95% CI, 1.03-1.17). Interestingly, patients taking antidepressants for other indications also had a higher risk of amputation compared with those not having depression or not taking antidepressants (HR, 1.08; 95% CI, 1.03-1.14). Having any diagnosis of depression or the need for antidepressants increased the mortality risk by 18% to 25% in the PAD cohort compared with those without depression and not taking antidepressants for any other indication. CONCLUSIONS: PAD patients with comorbid depression have a significantly higher risk of amputation and mortality than PAD patients without depression. Furthermore, untreated depression was associated with an increased amputation risk in the PAD population, more so than depression or other mental illness being treated by antidepressants. The underlying mechanisms for causality, if any, remain to be determined. The association of antidepressant treatment use with amputation risk should prompt further investigations into possible mechanistic links between untreated depression and vascular dysfunction.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Arya S, Lee S, Zahner GJ, et al. The association of comorbid depression with mortality and amputation in veterans with peripheral artery disease. J Vasc Surg. 2018. PMID: 29588133. doi:10.1016/j.jvs.2017.10.092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。